Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China flag China · Delayed Price · Currency is CNY
17.02
+0.37 (2.22%)
May 21, 2026, 3:00 PM CST

SHA:600521 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,8971,5041,5371,3421,3651,876
Trading Asset Securities
77.4775.9860.7993.04143.071.01
Cash & Short-Term Investments
1,9751,5801,5971,4351,5081,877
Cash Growth
-16.10%-1.07%11.28%-4.82%-19.66%-15.13%
Accounts Receivable
3,0353,1723,2352,5572,8311,906
Other Receivables
325.6940.0438.7628.447.4340.85
Receivables
3,3613,2123,2742,5852,8791,947
Inventory
3,6463,7123,4133,4323,3752,739
Prepaid Expenses
--5.114.25--
Other Current Assets
237.21237.32193.06164.61145.35250.18
Total Current Assets
9,2198,7428,4837,6227,9076,813
Property, Plant & Equipment
9,5679,4728,5717,9947,3075,961
Long-Term Investments
911.1770.06796.17785.25863.171,027
Goodwill
64.4564.4564.4564.4570.970.9
Other Intangible Assets
1,1401,1581,1961,1131,072970.6
Long-Term Deferred Tax Assets
192.09194.78189.67171.99183.9110.15
Long-Term Deferred Charges
1,1201,098960.16843.04737.88508.28
Other Long-Term Assets
2.392.931.096.459.467.87
Total Assets
22,21621,50320,26118,60018,15215,468
Accounts Payable
1,6171,8071,5851,3871,203881.79
Accrued Expenses
182.33340.64997.44735.43898.42791.6
Short-Term Debt
3,1102,8602,1101,5831,3971,314
Current Portion of Long-Term Debt
3,2973,261943.471,191630.76630.99
Current Portion of Leases
--14.1116.8216.7213.82
Current Income Taxes Payable
102.45126.3981.6891.14264.11187.9
Current Unearned Revenue
38.4434.9954.433.5167.766.71
Other Current Liabilities
756.69682.38189.5407.71321.64348.93
Total Current Liabilities
9,1059,1125,9765,4454,7994,236
Long-Term Debt
2,2381,8414,3944,0224,6783,498
Long-Term Leases
24.6975.6416.9944.9359.1466.41
Long-Term Unearned Revenue
643.52661.84698.95665.44532.09448.44
Other Long-Term Liabilities
350.8356.02155.9171.02338443.51
Total Liabilities
12,36212,04711,24110,34910,4068,692
Common Stock
1,4971,4971,4671,4831,4831,492
Additional Paid-In Capital
1,6121,6101,1851,2961,3221,381
Retained Earnings
6,5996,1956,3015,4704,9923,971
Treasury Stock
-100.01-100.01-300.05-416.91-484.25-521.84
Comprehensive Income & Other
238.54240.17244.47244.43233.98236.54
Total Common Equity
9,8479,4438,8988,0777,5476,559
Minority Interest
7.5513.35122.25174.26199.07217.48
Shareholders' Equity
9,8559,4569,0208,2517,7466,776
Total Liabilities & Equity
22,21621,50320,26118,60018,15215,468
Total Debt
8,6708,0387,4786,8586,7825,523
Net Cash (Debt)
-6,695-6,457-5,881-5,422-5,273-3,646
Net Cash Per Share
-4.46-4.36-4.06-3.72-3.61-2.54
Filing Date Shares Outstanding
1,4971,5311,4491,4681,4731,484
Total Common Shares Outstanding
1,4971,5311,4491,4681,4731,484
Working Capital
114.12-370.112,5072,1763,1092,577
Book Value Per Share
6.586.175.975.344.964.26
Tangible Book Value
8,6428,2207,6376,8996,4035,517
Tangible Book Value Per Share
5.775.375.104.544.183.56
Buildings
--4,5273,7572,8392,151
Machinery
--6,2285,546152.083,827
Construction In Progress
--2,1882,3172,8032,502
Source: S&P Global Market Intelligence. Standard template. Financial Sources.